Approval · Notice of Compliance 1072 · 2000
NIMBEX: Notice of Compliance 1072
Issued February 24, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1072
- Date
- February 24, 2000
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Non-depolarizing skeletal neuromuscular blocking agent
Products in this notice
Medicinal ingredients
- CISATRACURIUM BESYLATE 2 MG per ML
- CISATRACURIUM BESYLATE 10 MG per ML